Significant genetic alterations in the PI3K-mTOR pathway are observed in human endometrial cancer (Figure 1F) and the loss of Pten or overactivation of mTOR signaling results in the development of similar tumours in mouse models [19, 22]. This evidence concerns the gene MTOR and endometrial cancer.